Company denies claim
Government cancels Valneva’s £1.3bn Covid contract
The company denies claim that it is in breach of contract
Drugs developer Valneva has been told a deal to supply Covid vaccines has been terminated by the UK government which claims the company is in breach of contract.
The French company signed a £1.3 billion deal last September to produce 190 million doses of its experimental drug over five years at its facility in Livingston.
The company said in a statement today that it has received a termination notice from the UK Government in relation to the Supply Agreement for its COVID-19 vaccine candidate, VLA2001. The contract provides HMG with the right to terminate.
HMG has alleged that the company is in breach of its obligations under the supply agreement. The company said it strenuously denies the claim.
Valneva is continuing its VLA2001 development plan. Testing for its pivotal Phase 3 trial, Cov-Compare, is ongoing at Public Health England.